Skip to main content
. 2012 Feb 1;32(5):1811–1816. doi: 10.1523/JNEUROSCI.2722-11.2012

Table 1.

Demographic and experimental data of young and elderly subjects

Young (<46 years old) Elderly (≥46 years old)
N 69 69
Sex (F) 48 42
Age, years, mean ± SD (range) 28 ± 7.3 (17–45) 67.9 ± 8.5 (47–86)
Medication (N) 37
    Anticonvulsant 0
    Antidepressant 0
    Antihypertensive 32
        Beta-blocker 12
    ASA 11
    NSAID 3
    Antacids 4
    Steroids 3
    Statins 11
    Thyroxine 8
    Tamsulosin (α1a-selective alpha blocker) 4
    Others (Mictonorm, Norfloxacin, Phenprocoumon, Quinine Sulphate) 4
Stimulation intensity (mean ± SEM) 2.28 ± 0.81** 3.89 ± 0.25
Single-pulse A1 (μV; mean ± SEM) 4.62 ± 0.35 4.55 ± 0.39
Paired-pulse A1 (μV; mean ± SEM) 4.02 ± 0.27 4.32 ± 0.38
Paired-pulse A2 (μV; mean ± SEM) 1.77 ± 0.14** 2.72 ± 0.33
Ratio A2/A1 (mean ± SEM) 0.45 ± 0.03*** 0.64 ± 0.05
Two-point discrimination thresholds (mm; mean ± SEM) 3.33 ± 0.14
    For elderly subjects with ratios <1 (N = 13) 3.07 ± 0.18
    For elderly subjects with ratios >1 (N = 13) 3.58 ± 0.18

F, Female; ASA, acetylsalicylic acid; NSAID, non-steroidal anti-inflammatory drugs.

** p < 0.01;

*** p < 0.001.